EPHA2 and bone neoplasm: To investigate the efficacy of an EphA2 pharmacologic inhibitor on breast cancer–induced osteolysis, we treated bone tumor–bearing animals with EphA2 small‐molecule inhibitor ALW‐II‐41‐2725, 43 or vehicle control.